British Skull Base Society Consensus on Vestibular Schwannoma Surveillance

Abstract

Objective

Surveillance plays a crucial role in managing patients with vestibular schwannomas (VSs). Consensus is lacking on the optimal duration, frequency, and modality of imaging. Standardizing this approach would ensure safe and effective care, reduce patient distress, and promote consistency in management decisions among clinicians.

Methods

In July 2022, a multi-disciplinary Delphi consensus was conducted at the British Skull Base Society Meeting. Expert United Kingdom-based skull-base surgeons and neuroradiologists were presented semi-systematic literature reviews summarizing current evidence on VS management. Anonymized opinions were collated and discussed to reach a majority vote, which was deemed the final consensus opinion.

Results

Recommendations for VS managed by surveillance are: (1) surveillance frequency should decrease over time; (2) surveillance may be discontinued when the remaining lifetime risk of VS growth is <0.5% (∼8.5 years); (3) factors such as age, VS size, VS location, and cystic components should be considered. Surveillance after surgery or radiotherapy has limited evidence but recommendations are: (4) surveillance should be adjusted based on residual tumor size or nodular enhancement. Imaging modality and sequences are recommended to be (5) high-resolution magnetic resonance imaging with T1, T2, FIESTA/CISS multiplanar sequences, contrast is not required in untreated cases, and linear reporting of measurements is pragmatically sufficient.

Conclusion

This consensus and literature review provides an evidence and expert opinion–based guide to help clinicians with the surveillance of patients with VS. Further research should focus on better understanding the dynamic nature of growth risks and the growth characteristics of postintervention VS to enable personalized growth risk stratification.

Keywords

consensus - vestibular schwannomas - surveillance - growth risk

^* The first two authors contributed equally to the paper.

Publikationsverlauf

Eingereicht: 26. Februar 2024

Angenommen: 06. Oktober 2024

Artikel online veröffentlicht:
05. November 2024

• References

• 1 Babu R, Sharma R, Bagley JH, Hatef J, Friedman AH, Adamson C. Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management. J Neurosurg 2013; 119 (01) 121-130
• 2 Marinelli JP, Grossardt BR, Lohse CM, Carlson ML. Prevalence of sporadic vestibular schwannoma: reconciling temporal bone, radiologic, and population-based studies. Otol Neurotol 2019; 40 (03) 384-390
• 3 Axon P. Second National Vestibular Schwannoma Audit Report 2019. Technical Report. British Skull Base Society; 2019
• 4 Zanoletti E, Mazzoni A, Martini A. et al. Surgery of the lateral skull base: a 50-year endeavour. Acta Otorhinolaryngol Ital 2019; 39 (Suppl. 01) S1-S146
• 5 Stangerup SE, Caye-Thomasen P. Epidemiology and natural history of vestibular schwannomas. Otolaryngol Clin North Am 2012; 45 (02) 257-268 , vii
• 6 Shapey J, Barkas K, Connor S. et al. A standardised pathway for the surveillance of stable vestibular schwannoma. Ann R Coll Surg Engl 2018; 100 (03) 216-220
• 7 Kondziolka D, Lunsford LD, Flickinger JC. Acoustic tumors: operation versus radiation–making sense of opposing viewpoints. Part II. Acoustic neuromas: sorting out management options. Clin Neurosurg 2003; 50: 313-328
• 8 OCEBM Levels of Evidence Working Group*. “The Oxford Levels of Evidence 2”. Oxford Centre for Evidence-Based Medicine. Accessed October 17, 2024 at: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence
• 9 Paldor I, Chen AS, Kaye AH. Growth rate of vestibular schwannoma. J Clin Neurosci 2016; 32: 1-8
• 10 Moffat DA, Kasbekar A, Axon PR, Lloyd SK. Growth characteristics of vestibular schwannomas. Otol Neurotol 2012; 33 (06) 1053-1058
• 11 Reznitsky M, Petersen MMBS, West N, Stangerup SE, Cayé-Thomasen P. The natural history of vestibular schwannoma growth-prospective 40-year data from an unselected national cohort. Neuro-oncol 2021; 23 (05) 827-836
• 12 Sethi M, Borsetto D, Cho Y. et al. The conditional probability of vestibular schwannoma growth at different time points after initial stability on an observational protocol. Otol Neurotol 2020; 41 (02) 250-257
• 13 Borsetto D, Sethi M, Clarkson K. et al. Evidence-based surveillance protocol for vestibular schwannomas: a long-term analysis of tumor growth using conditional probability. J Neurosurg 2022; 137 (04) 1026-1033
• 14 Borsetto D, Gair J, Kenyon O. et al. When should we stop scanning older patients with vestibular schwannomas?. J Neurol Surg B Skull Base 2019; 80 (04) 333-337
• 15 Stangerup SE, Caye-Thomasen P, Tos M, Thomsen J. The natural history of vestibular schwannoma. Otol Neurotol 2006; 27 (04) 547-552
• 16 Martin TP, Senthil L, Chavda SV, Walsh R, Irving RM. A protocol for the conservative management of vestibular schwannomas. Otol Neurotol 2009; 30 (03) 381-385
• 17 Goldbrunner R, Weller M, Regis J. et al. EANO guideline on the diagnosis and treatment of vestibular schwannoma. Neuro-oncol 2020; 22 (01) 31-45
• 18 Manuele FA. Acceptable risk: time for SH&E professionals to adopt the concept. Prof Saf 2010; 55 (05) 30-38
• 19 Agrawal Y, Clark JH, Limb CJ, Niparko JK, Francis HW. Predictors of vestibular schwannoma growth and clinical implications. Otol Neurotol 2010; 31 (05) 807-812
• 20 Sethi M. et al. Determinants of vestibular schwannoma growth. Otol Neurotol 2021; 42 (05) 746-754
• 21 Patnaik U, Prasad SC, Tutar H, Giannuzzi AL, Russo A, Sanna M. The long-term outcomes of wait-and-scan and the role of radiotherapy in the management of vestibular schwannomas. Otol Neurotol 2015; 36 (04) 638-646
• 22 Roehm PC, Gantz BJ. Management of acoustic neuromas in patients 65 years or older. Otol Neurotol 2007; 28 (05) 708-714
• 23 Timmer FC, Artz JC, Beynon AJ. et al. Prediction of vestibular schwannoma growth: a novel rule based on clinical symptomatology. Ann Otol Rhinol Laryngol 2011; 120 (12) 807-813
• 24 Whitley H, Benedict NT, Tringali S. et al. Identifying factors associated with the growth of vestibular schwannomas: a systematic review. World Neurosurg 2021; 149: e766-e779
• 25 Eljamel S, Hussain M, Eljamel MS. Should initial surveillance of vestibular schwannoma be abandoned?. Skull Base 2011; 21 (01) 59-64
• 26 Benech F, Perez R, Fontanella MM, Morra B, Albera R, Ducati A. Cystic versus solid vestibular schwannomas: a series of 80 grade III-IV patients. Neurosurg Rev 2005; 28 (03) 209-213
• 27 Carlson ML, Van Abel KM, Driscoll CL. et al. Magnetic resonance imaging surveillance following vestibular schwannoma resection. Laryngoscope 2012; 122 (02) 378-388
• 28 Bennett ML, Jackson CG, Kaufmann R, Warren F. Postoperative imaging of vestibular schwannomas. Otolaryngol Head Neck Surg 2008; 138 (05) 667-671
• 29 Miller ME, Lin H, Mastrodimos B, Cueva RA. Long-term MRI surveillance after microsurgery for vestibular schwannoma. Laryngoscope 2017; 127 (09) 2132-2138
• 30 Lemée J-M, Delahaye C, Laccourreye L, Mercier P, Fournier HD. Post-surgical vestibular schwannoma remnant tumors: what to do?. Neurochirurgie 2014; 60 (05) 205-215
• 31 Kim W-H. et al. The use of cochlear-enhancement imaging to predict hearing preservation following vestibular schwannoma removal. J Neurosurg Sci 2024; 68 (02) 174-180
• 32 Dunn IF, Bi WL, Mukundan S. et al. Congress of neurological surgeons systematic review and evidence-based guidelines on the role of imaging in the diagnosis and management of patients with vestibular schwannomas. Neurosurgery 2018; 82 (02) E32-E34
• 33 Murphy ES, Suh JH. Radiotherapy for vestibular schwannomas: a critical review. Int J Radiat Oncol Biol Phys 2011; 79 (04) 985-997
• 34 Weissman JL, Hirsch BE, Fukui MB, Rudy TE. The evolving MR appearance of structures in the internal auditory canal after removal of an acoustic neuroma. AJNR Am J Neuroradiol 1997; 18 (02) 313-323
• 35 Nagano O, Serizawa T, Higuchi Y. et al. Tumor shrinkage of vestibular schwannomas after Gamma Knife surgery: results after more than 5 years of follow-up. J Neurosurg 2010; 113 (Suppl): 122-127
• 36 Matsuo T, Okunaga T, Kamada K, Izumo T, Hayashi N, Nagata I. Long-term follow-up results of linear accelerator-based radiosurgery for vestibular schwannoma using serial three-dimensional spoiled gradient-echo MRI. J Clin Neurosci 2015; 22 (02) 320-325
• 37 Okunaga T, Matsuo T, Hayashi N. et al. Linear accelerator radiosurgery for vestibular schwannoma: measuring tumor volume changes on serial three-dimensional spoiled gradient-echo magnetic resonance images. J Neurosurg 2005; 103 (01) 53-58
• 38 Germano IM, Sheehan J, Parish J. et al. Congress of Neurological Surgeons systematic review and evidence-based guidelines on the role of radiosurgery and radiation therapy in the management of patients with vestibular schwannomas. Neurosurgery 2018; 82 (02) E49-E51
• 39 Zealley IA, Cooper RC, Clifford KM. et al. MRI screening for acoustic neuroma: a comparison of fast spin echo and contrast enhanced imaging in 1233 patients. Br J Radiol 2000; 73 (867) 242-247
• 40 Singh K, Singh MP, Thukral C, Rao K, Singh K, Singh A. Role of magnetic resonance imaging in evaluation of cerebellopontine angle schwannomas. Indian J Otolaryngol Head Neck Surg 2015; 67 (01) 21-27
• 41 Stuckey SL, Harris AJ, Mannolini SM. Detection of acoustic schwannoma: use of constructive interference in the steady state three-dimensional MR. AJNR Am J Neuroradiol 1996; 17 (07) 1219-1225
• 42 Hermans R, Van der Goten A, De Foer B, Baert AL. MRI screening for acoustic neuroma without gadolinium: value of 3DFT-CISS sequence. Neuroradiology 1997; 39 (08) 593-598
• 43 Dang L, Tu NC, Chan EY. Current imaging tools for vestibular schwannoma. Curr Opin Otolaryngol Head Neck Surg 2020; 28 (05) 302-307
• 44 Selleck AM, Rodriguez JD, Brown KD. Vestibular schwannoma measurements-is volumetric analysis clinically necessary?. Otol Neurotol 2021; 42 (06) 906-911